Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
325 12 |
Ultima descărcare din IBN: 2024-05-12 18:44 |
SM ISO690:2012 GHICAVÂI, Victor, CEBAN, Emil, GUŢU, Constantin, TĂNASE, Dorin, SCUTELNIC, Ghenadie, TUCHILA, Viorel, MILICI, Ilie, TRICOLICI, Ghenadie, PLEȘCO, Sergiu. Eficacitatea medicamentului adenoprosin in tratamentul hiperplaziei prostatice benigne (BPH). In: Arta Medica , 2011, nr. 2S(45), pp. 42-44. ISSN 1810-1852. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Arta Medica | ||
Numărul 2S(45) / 2011 / ISSN 1810-1852 /ISSNe 1810-1879 | ||
|
||
Pag. 42-44 | ||
Descarcă PDF | ||
Rezumat | ||
Conservative treatment occupies new positions in the therapy of BPH. This is due to several factors, including the increasing number of elderly patients and increasing of their associated diseases (60-90%), which does not allow radical treatment. Efficacy of conservative treatment is already proven by many clinical investigations, which induces an increased popularity of this method of treatment among urologists. The purpose of conservative treatment is not only to defer surgery in time, but is to obtain a high effect of sclerosis of prostate adenoma, and thereby cancellation of the surgery. Currently, pharmaceutical companies come with new and new groups of drugs, most effective in the treatment of BPH. One direction of future therapy in the treatment of BPH is bio-regulatory therapy with suppositories “Adenoprosin”, which is used successfully in the pharmacological treatment of prostate adenoma complicated with inflammatory processes such as acute and chronic prostatitis. |
||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Ghicavâi, V.I.</dc:creator> <dc:creator>Ceban, E.D.</dc:creator> <dc:creator>Guţu, C.V.</dc:creator> <dc:creator>Tănase, D.</dc:creator> <dc:creator>Scutelnic, G.A.</dc:creator> <dc:creator>Tuchila, V.</dc:creator> <dc:creator>Milici, I.</dc:creator> <dc:creator>Tricolici, G.</dc:creator> <dc:creator>Pleșco, S.</dc:creator> <dc:date>2011-08-01</dc:date> <dc:description xml:lang='en'><p>Conservative treatment occupies new positions in the therapy of BPH. This is due to several factors, including the increasing number of elderly patients and increasing of their associated diseases (60-90%), which does not allow radical treatment. Efficacy of conservative treatment is already proven by many clinical investigations, which induces an increased popularity of this method of treatment among urologists. The purpose of conservative treatment is not only to defer surgery in time, but is to obtain a high effect of sclerosis of prostate adenoma, and thereby cancellation of the surgery. Currently, pharmaceutical companies come with new and new groups of drugs, most effective in the treatment of BPH. One direction of future therapy in the treatment of BPH is bio-regulatory therapy with suppositories “Adenoprosin”, which is used successfully in the pharmacological treatment of prostate adenoma complicated with inflammatory processes such as acute and chronic prostatitis.</p></dc:description> <dc:source>Arta Medica 45 (2S) 42-44</dc:source> <dc:title>Eficacitatea medicamentului adenoprosin in tratamentul hiperplaziei prostatice benigne (BPH)</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>